Literature DB >> 2870018

Assignment of the human tyrosine aminotransferase gene to chromosome 16.

E Natt, F T Kao, R Rettenmeier, G Scherer.   

Abstract

The liver enzyme tyrosine aminotransferase (TAT; EC 2.6.1.5) catalyzes the rate-limiting step in the catabolic pathway of tyrosine. Deficiency in TAT enzyme activity underlies the autosomally inherited disorder tyrosinemia II (Richner-Hanhart syndrome). Using a human TAT cDNA clone as hybridization probe, we have determined the chromosomal location of the TAT structural gene by Southern blot analysis of DNAs from a series of human X rodent somatic cell hybrids. The results assign the TAT gene to human chromosome 16.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2870018     DOI： 10.1007/bf00291882

Source DB:  PubMed          Journal:  Hum Genet        ISSN： 0340-6717            Impact factor:   4.132


  17 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

Review 2.  Genetic control of morphogenetic and biochemical differentiation: lethal albino deletions in the mouse.

Authors:  S Gluecksohn-Waelsch
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

3.  Report of the Committee on the Genetic Constitution of Chromosomes 13, 14, 15 and 16.

Authors:  D R Cox; T Gedde-Dahl
Journal:  Cytogenet Cell Genet       Date:  1985

4.  Isolation and characterization of the rat tyrosine aminotransferase gene.

Authors:  T Shinomiya; G Scherer; W Schmid; H Zentgraf; G Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

5.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

6.  Isolation and sequence characterization of a cDNA clone of human antithrombin III.

Authors:  T Chandra; R Stackhouse; V J Kidd; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

7.  Development of tyrosine aminotransferase and para-hydroxyphenylpyruvate dioxygenase activities in fetal and neonatal human liver.

Authors:  J J Ohisalo; T Laskowska-Klita; S M Andersson
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

8.  Purification and properties of human liver tyrosine aminotransferase.

Authors:  S M Andersson; J P Pispa
Journal:  Clin Chim Acta       Date:  1982-10-27       Impact factor: 3.786

9.  Genetic mapping of the structural gene for antithrombin III to human chromosome 1.

Authors:  F T Kao; H G Morse; M L Law; A Lidsky; T Chandra; S L Woo
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

10.  Isolation, characterization and chromosomal mapping of the mouse tyrosine aminotransferase gene.

Authors:  G Müller; G Scherer; H Zentgraf; S Ruppert; B Herrmann; H Lehrach; G Schütz
Journal:  J Mol Biol       Date:  1985-08-05       Impact factor: 5.469
View more
  7 in total

1.  The coding sequence for the 32,000-dalton pulmonary surfactant-associated protein A is located on chromosome 10 and identifies two separate restriction-fragment-length polymorphisms.

Authors:  J H Fisher; F T Kao; C Jones; R T White; B J Benson; R J Mason
Journal:  Am J Hum Genet       Date:  1987-06       Impact factor: 11.025

2.  Tyrosine aminotransferase is involved in the oxidative stress response by metabolizing meta-tyrosine in Caenorhabditis elegans.

Authors:  Brett R Ipson; Rebecca A Green; John T Wilson; Jacob N Watson; Kym F Faull; Alfred L Fisher
Journal:  J Biol Chem       Date:  2019-05-01       Impact factor: 5.157

3.  L-tyrosine induces DNA damage in brain and blood of rats.

Authors:  Samira D T De Prá; Gabriela K Ferreira; Milena Carvalho-Silva; Júlia S Vieira; Giselli Scaini; Daniela D Leffa; Gabriela E Fagundes; Bruno N Bristot; Gabriela D Borges; Gustavo C Ferreira; Patrícia F Schuck; Vanessa M Andrade; Emilio L Streck
Journal:  Neurochem Res       Date:  2013-12-03       Impact factor: 3.996

4.  The human tyrosine aminotransferase gene: characterization of restriction fragment length polymorphisms and haplotype analysis in a family with tyrosinemia type II.

Authors:  E M Westphal; E Natt; T Grimm; M Odievre; G Scherer
Journal:  Hum Genet       Date:  1988-07       Impact factor: 4.132

5.  Inherited and de novo deletion of the tyrosine aminotransferase gene locus at 16q22.1----q22.3 in a patient with tyrosinemia type II.

Authors:  E Natt; E M Westphal; S E Toth-Fejel; R E Magenis; N R Buist; R Rettenmeier; G Scherer
Journal:  Hum Genet       Date:  1987-12       Impact factor: 4.132

6.  Isolation and characterization of the human tyrosine aminotransferase gene.

Authors:  R Rettenmeier; E Natt; H Zentgraf; G Scherer
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

7.  Plantar keratoderma: a manifestation of tyrosinemia type II (Richner-Hanhart syndrome).

Authors:  Jihad T Al-Ratrout; Mohammed Al-Muzian; Mona Al-Nazer; Naseem A Ansari
Journal:  Ann Saudi Med       Date:  2005 Sep-Oct       Impact factor: 1.526
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.